Skip to main content
Company Profiles

Company Profiles Need Both Lenses: Five Forces and PESTLE, Not a Choice

Company profiles that rely on just one framework miss the full picture. I argue for combining Porter's Five Forces with PESTLE—and here's why.

Imagine you're an industry analyst at a boutique firm, tasked with profiling a mid-sized pharmaceutical company. You pull up the usual data: market share, revenue growth, maybe a quick Porter's Five Forces sketch. You note that supplier power is high because of specialized APIs, and you flag that new entrants are a moderate threat thanks to regulatory hurdles. Then you present your findings, and your client asks, “What about the Inflation Reduction Act's impact on drug pricing? What about the AI-driven shift in R&D?” You freeze. That's the moment you realize: you've been wearing one lens, and you've missed the macro picture.

This scenario is more common than you'd think. Too many company profiles in industry analysis are built on a single framework—either Porter's Five Forces for the competitive environment or PESTLE for the macro trends. The CFA Institute, which knows a thing or two about rigorous analysis, explicitly recommends using both: Five Forces to interpret the competitive environment and PESTLE to understand external trends (CFA Institute). That's not a suggestion; it's a necessity. My thesis is simple: if you're writing a company profile and you choose one framework over the other, you're producing a partial analysis that will mislead more than it informs. You need both, integrated deliberately, not as a token checkbox.

The Case for Five Forces: It's the Competitive Core

Let's start with the foundation. Porter's Five Forces, introduced by Michael Porter in his 1979 Harvard Business Review article, remains a cornerstone of industry analysis (Harvard Business School). The framework analyzes the level of competition within a market through five forces: threat of new entrants, substitutes, supplier power, buyer power, and competitive rivalry. The stronger these forces, the lower the industry's profit potential (CFA Institute). For a company profile, this is where you get the competitive dynamics that directly affect a firm's margins and strategy.

Consider the pharmaceutical industry. Supplier power is high because a handful of firms control key active ingredients. Buyer power is moderate, but government payers are flexing their muscles. Rivalry is intense, with patent cliffs looming. These forces determine how the economic value an industry creates is apportioned—it can be drained away through rivalry, bargained away by suppliers or customers, or constrained by new entrants and substitutes (Harvard Business School). Without this analysis, you can't explain why a company's margins are shrinking or why it's pivoting to biologics. Five Forces gives you the competitive anatomy.

But Five Forces Alone Misses the Macro Shifts

Here's the problem: Five Forces is largely static. It assumes the structural forces are stable, but they're not. That's where PESTLE comes in. PESTLE examines Political, Economic, Social, Technological, Legal, and Environmental factors that influence an industry (CFA Institute). Political factors include government policies, trade policy, and regulation trends (Washington State University Libraries). Economic factors cover growth, inflation, interest rates, and labor costs (Washington State University Libraries). Social factors touch demographics and consumer attitudes (Washington State University Libraries). And environmental factors have grown in importance due to scarcity of raw materials and sustainability pressures (Washington State University Libraries).

Take the pharmaceutical company again. In 2023, the global insights industry grew about 8.0%, but Asia Pacific was the fastest-growing region, at 9.5% (ESOMAR via Research World (Asia Pacific)). That's a macro trend that shifts where you should focus your profile. But more importantly, consider the technological factor: about 47% of researchers globally use AI regularly in market research, and 83% planned to invest in AI in 2025 (Similarweb / Research and Markets). That technological shift is reshaping how pharma companies do clinical trials and market analysis. A Five Forces-only profile would ignore this, leaving your client blindsided by an AI-driven disruption.

The Integration Imperative: How to Combine Them

So how do you integrate? You don't just list Five Forces and then PESTLE in separate sections; you weave them together. Start with PESTLE to set the macro stage. Identify the political, economic, social, technological, legal, and environmental trends that are reshaping the industry. Then, for each trend, ask: How does this alter the five forces? For example, a new regulation (political) might raise barriers to entry (reducing the threat of new entrants). A technological breakthrough (technological) might increase substitution threats. This is the analytical work that separates a mediocre profile from a sharp one.

Here's a concrete example using the market research industry itself. The global market research industry was valued at about $76.37 billion in 2021 and was projected to reach over $108 billion by 2026 (Similarweb / Research and Markets). ESOMAR's 2024 report estimated the global insights industry surpassed US$140 billion in 2023, expected to surpass US$150 billion by 2024 (ESOMAR via Research World). Within this, the research software sector grew 12.4% in 2023, while the mature market research sector grew only 4.6% (ESOMAR via Research World). That's a technological shift (software eating research) that fundamentally changes the competitive dynamics: new entrants with AI-driven tools are threatening traditional firms. A Porter's Five Forces analysis of a market research firm would show high rivalry and low entry barriers, but only by overlaying PESTLE's technological factor do you see that the real threat is from software startups, not traditional competitors.

Addressing the Counter-Argument: 'But We Have Limited Time'

You might argue, “We don't have time to do both frameworks in every company profile.” I hear that. Analysts are pressed for time, and clients want quick answers. But consider this: the cost of a partial analysis is higher than the cost of the extra hour it takes to overlay PESTLE. If you skip the macro lens, you risk missing a regulatory shift that could tank a company's valuation. The CFA Institute's guidance to use both isn't a luxury; it's a best practice. And you don't have to write a 50-page report. A tight integration of the two frameworks can be done in a few paragraphs, as long as you're deliberate.

Moreover, the data to support both lenses is readily available. For example, the Herfindahl-Hirschman Index (HHI) is a tool used by the US DOJ to measure market concentration; it's the sum of the squares of market shares, approaching zero in many small firms and reaching 10,000 in a monopoly (US DOJ Antitrust Division). That's a quantitative measure that can enrich your Five Forces analysis. On the PESTLE side, you have macroeconomic data from sources like ESOMAR. The integration isn't about more work; it's about smarter work.

My Recommendation: Make Both Lenses Non-Negotiable

My advice is simple: adopt a policy that every company profile must include both a Five Forces and a PESTLE analysis, integrated into a single narrative. Don't treat them as separate sections; treat them as two sides of the same coin. This will not only improve the quality of your analysis but also differentiate you from analysts who rely on a single framework. The industry is moving toward more sophisticated analysis, and those who adapt will lead.

To give you a practical checklist, here's what I recommend for each profile:

  • Run a PESTLE scan to identify the 3-4 most impactful macro trends.
  • For each trend, assess its effect on each of the five forces.
  • Use quantitative tools like HHI to ground your competitive analysis.
  • Weave the findings into a cohesive story, not a list.

This approach is not just theoretical; it's actionable. In the pharmaceutical example, you'd note that the Inflation Reduction Act's drug pricing provisions (political) increase buyer power, while AI-driven drug discovery (technological) lowers entry barriers for tech-savvy startups. That's the kind of insight that clients pay for.

Sources

  • CFA Institute - https://www.cfainstitute.org/insights/professional-learning/refresher-readings/2026/industry-and-competitive-analysis
  • Similarweb / Research and Markets - https://www.similarweb.com/blog/research/market-research/market-research-stats/
  • Harvard Business School - https://www.hbs.edu/faculty/Pages/item.aspx?lang=en&num=34522
  • Washington State University Libraries - https://libguides.libraries.wsu.edu/c.php?g=294263&p=4358409
  • ESOMAR via Research World - https://researchworld.com/articles/drivers-of-our-142bn-insights-industry
  • ESOMAR via Research World (Asia Pacific) - https://researchworld.com/articles/the-remarkable-ascent-of-asia-pacific-in-global-insights
  • US DOJ Antitrust Division - https://www.justice.gov/atr/herfindahl-hirschman-index

Share this article:

Comments (0)

No comments yet. Be the first to comment!